Your browser doesn't support javascript.
Usefulness of the COVID-GRAM and CURB-65 scores for predicting severity in patients with COVID-19.
Armiñanzas, Carlos; Arnaiz de Las Revillas, Francisco; Gutiérrez Cuadra, Manuel; Arnaiz, Ana; Fernández Sampedro, Marta; González-Rico, Claudia; Ferrer, Diego; Mora, Víctor; Suberviola, Borja; Latorre, Maite; Calvo, Jorge; Olmos, José Manuel; Cifrián, José Manuel; Fariñas, María Carmen.
  • Armiñanzas C; Service of Infectious Diseases, Hospital Universitario Marqués de Valdecilla, University of Cantabria, IDIVAL, Santander, Spain. Electronic address: carlos.arminanzas@scsalud.es.
  • Arnaiz de Las Revillas F; Service of Infectious Diseases, Hospital Universitario Marqués de Valdecilla, University of Cantabria, IDIVAL, Santander, Spain. Electronic address: francisco.arnaizlasrevillas@scsalud.es.
  • Gutiérrez Cuadra M; Service of Infectious Diseases, Hospital Universitario Marqués de Valdecilla, University of Cantabria, IDIVAL, Santander, Spain. Electronic address: manuel.gutierrezc@scsalud.es.
  • Arnaiz A; Service of Infectious Diseases, Hospital Universitario Marqués de Valdecilla, University of Cantabria, IDIVAL, Santander, Spain. Electronic address: anam.arnaiz@scsalud.es.
  • Fernández Sampedro M; Service of Infectious Diseases, Hospital Universitario Marqués de Valdecilla, University of Cantabria, IDIVAL, Santander, Spain. Electronic address: marta.fernandezs@scsalud.es.
  • González-Rico C; Service of Infectious Diseases, Hospital Universitario Marqués de Valdecilla, University of Cantabria, IDIVAL, Santander, Spain. Electronic address: claudia.glez.rico@gmail.com.
  • Ferrer D; Service of Respiratory Medicine, Hospital Universitario Marqués de Valdecilla, Santander, Spain. Electronic address: diegojose.ferrer@scsalud.es.
  • Mora V; Service of Respiratory Medicine, Hospital Universitario Marqués de Valdecilla, Santander, Spain. Electronic address: victormanuel.mora@scsalud.es.
  • Suberviola B; Service of Intensive Care, Hospital Universitario Marqués de Valdecilla, Santander, Spain. Electronic address: borja.suberviola@scsalud.es.
  • Latorre M; Service of Internal Medicine, Hospital Universitario Marqués de Valdecilla, Santander, Spain. Electronic address: maite.latorre@scsalud.es.
  • Calvo J; Service of Microbiology, Hospital Universitario Marqués de Valdecilla, University of Cantabria, IDIVAL, Santander, Spain. Electronic address: jorge.calvo@scsalud.es.
  • Olmos JM; Service of Internal Medicine, Hospital Universitario Marqués de Valdecilla, Santander, Spain. Electronic address: josemanuel.olmos@scsalud.es.
  • Cifrián JM; Service of Respiratory Medicine, Hospital Universitario Marqués de Valdecilla, Santander, Spain. Electronic address: josemanuel.cifrian@scsalud.es.
  • Fariñas MC; Service of Infectious Diseases, Hospital Universitario Marqués de Valdecilla, University of Cantabria, IDIVAL, Santander, Spain. Electronic address: mcarmen.farinas@scsalud.es.
Int J Infect Dis ; 108: 282-288, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1351700
ABSTRACT

AIM:

The aim of this study was to determine the usefulness of COVID-GRAM and CURB-65 scores as predictors of the severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Caucasian patients.

METHODS:

This was a retrospective observational study including all adults with SARS-CoV-2 infection admitted to Hospital Universitario Marqués de Valdecilla from February to May 2020. Patients were stratified according to COVID-GRAM and CURB-65 scores as being at low-medium or high risk of critical illness. Univariate analysis, multivariate logistic regression models, receiver operating characteristic curve, and area under the curve (AUC) were calculated.

RESULTS:

A total of 523 patients were included (51.8% male, 48.2% female; mean age 65.63 years (standard deviation 17.89 years)), of whom 110 (21%) presented a critical illness (intensive care unit admission 10.3%, 30-day mortality 13.8%). According to the COVID-GRAM score, 122 (23.33%) patients were classified as high risk; 197 (37.7%) presented a CURB-65 score ≥2. A significantly greater proportion of patients with critical illness had a high COVID-GRAM score (64.5% vs 30.5%; P < 0.001). The COVID-GRAM score emerged as an independent predictor of critical illness (odds ratio 9.40, 95% confidence interval 5.51-16.04; P < 0.001), with an AUC of 0.779. A high COVID-GRAM score showed an AUC of 0.88 for the prediction of 30-day mortality, while a CURB-65 ≥2 showed an AUC of 0.83.

CONCLUSIONS:

The COVID-GRAM score may be a useful tool for evaluating the risk of critical illness in Caucasian patients with SARS-CoV-2 infection. The CURB-65 score could be considered as an alternative.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article